Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrossword Cybersecurity Regulatory News (CCS)

  • This share is currently suspended. It was suspended at a price of 1.75
  • There is currently no data for CCS

Trading Update

19 Jan 2021 07:00

RNS Number : 0930M
Crossword Cybersecurity PLC
19 January 2021
 

Crossword Cybersecurity Plc

Trading Update

 

19 January 2021 - London, UK - Crossword Cybersecurity Plc (AIM:CCS, "Crossword", the "Company" or the "Group"), the technology commercialisation company focused on cyber security and risk management, is pleased to announce that it expects to report results for the Financial Year ended 31 December 2020, in line with market expectations, in April 2021.

 

Overall revenue during the year is expected to show an increase of 25% to £1.6m. Within that, revenues from product and consulting revenue are anticipated to have expanded by 39%, reflecting the Company's shift from software development services to its core of product and consulting revenue. Cash balances as at 31 December were £958k.

 

Software and process development continued during 2020 with the launch of Rizikon Pro in July 2020. Rizikon Pro is an out-of-the-box, online SaaS solution, offered on a pay-as-you-go basis, giving smaller and medium sized organisations access to a set of core easy-to-use supplier assurance platform features, at a lower cost. Modules can be chosen according to need, meaning customers only pay for the features they use, and can be expanded as required. Rizikon Pro is transforming the sales model with a much shorter sales cycle and impressively high conversion from trials to paying clients.

 

Crossword continues to have several large bids in its pipeline. There were two multi-million-pound opportunities which we alluded to in an RNS on 28 September 2020 for which the process concluded in 2020; one where we received notice that procurement had been abandoned by the UK Government department, and the other where we were unsuccessful.

 

In November 2020, Crossword began working with Verifiable Credentials Ltd on its Innovate UK funded-project to allow NHS laboratories to issue Covid-19 immunity certificates. In addition, in December 2020, Crossword was awarded an Innovate UK grant with a university partner and two well-known British Manufacturing businesses, to investigate the issues around effective Manufacturing Supply Chain risk management and possible solutions.

 

In 2020, the consulting division continued to grow in a range of high-profile sectors including legal, insurance and financial services. Work commenced on a major project for one of the world's largest, global S&P500 insurance brokers.

 

Tom Ilube, CEO of Crossword, commented;

"Crossword emerged from a challenging 2020 in great shape, meeting market expectations of 25% revenue growth. We are looking forward to an exciting year ahead, accelerating roll out of Rizikon Pro, securing major consulting clients, adding to our cyber security product portfolio, and expanding internationally. We expect the revenue growth rate to more than double in 2021."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the UK Market Abuse Regulation. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

Contacts

Crossword Cybersecurity plc - Tel: +44 (0) 20 3953 8460

Email: info@crosswordcybersecurity.com

Tom Ilube, Chief Executive Officer

Mary Dowd, Finance Director

 

Grant Thornton (Nominated Adviser) - Tel: +44 (0) 20 7383 5100

Colin Aaronson / Jamie Barklem

 

Hybridan LLP (Broker) - Tel: +44 (0)203 764 2341

Claire Louise Noyce

 

For media enquiries contact:

Duncan Gurney, GingerPR

duncan@gingerpr.co.uk - Tel: +44 (0)1932 485 300

 

About Crossword Cybersecurity plc

Crossword Cybersecurity plc focuses on the development and commercialisation of university research-based cyber security and risk management related software and cyber security consulting. The Group's specialist cyber security product development and software engineering teams work with its university partners to develop the research concept into a fully-fledged commercial product that it will then take to market. The Group's aim is to build up a portfolio of revenue generating, intellectual property based, cyber security products. Rizikon Assurance, Crossword's leading product, is a SaaS platform that enables medium to large companies to assess and manage all risks from their suppliers. Nixer CyberML, Crossword's most recently launched product, is a new tool for businesses that want to solve advanced security and cybercrime problems, such as detecting and dealing with compromised accounts, fraud, and in-application denial of service attacks. Crossword's team of expert cyber security consultants leverages years of experience in national security, defence and commercial cyber intelligence and operations to provide bespoke advice tailored to its clients' business needs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFSFAAEFSEIF
Date   Source Headline
29th Nov 20073:54 pmRNSResult of AGM
7th Nov 20079:50 amRNSNotice of AGM
23rd Oct 200712:02 pmRNSContract wins
22nd Oct 20077:01 amRNSUpdate on Retail Division
4th Oct 200712:17 pmRNSStrategic Review
27th Sep 20073:05 pmRNSBoard changes
3rd Sep 200710:26 amRNSFinal Results
24th Aug 200711:29 amRNSAIM Rule 26 information
21st Aug 200712:12 pmRNSChange of registered office
20th Aug 20074:02 pmRNSChange of Broker
20th Jul 200712:59 pmRNSNotice of deferred results
3rd Jul 200710:15 amRNSDirectorate Change
29th Jun 20073:55 pmRNSChange of Adviser
26th Jun 20077:02 amRNSBoard Changes
6th Jun 200712:42 pmRNSTotal Voting Rights
31st May 20076:07 pmRNSResult of EGM
31st May 200712:43 pmRNSConfirmation of EGM Notice
23rd May 20071:05 pmRNSInterests in Shares
23rd May 20079:44 amRNSDirector/PDMR Shareholding
23rd May 20077:02 amRNSStrategic update
22nd May 20077:03 amRNSMarket Update
11th May 200712:25 pmRNSMAJOR INTERESTS IN SHARES
11th May 200712:19 pmRNSMAJOR INTERESTS IN SHARES
11th May 200712:08 pmRNSAdditional Listing
3rd May 20075:47 pmRNSNotice of EGM
3rd May 20071:47 pmRNSTotal Voting Rights
2nd May 20076:27 pmRNSHolding(s) in Company
1st May 20072:41 pmRNSDirector/PDMR Shareholding
26th Apr 200712:39 pmRNSBoard Appointment
16th Apr 20071:29 pmRNSStmnt re Requisition for EGM
2nd Apr 20077:01 amRNSTrading Statement
8th Jan 200712:07 pmRNSDirector Shareholding
4th Jan 20075:10 pmRNSDirector / PDMR Shareholding
22nd Dec 20061:22 pmRNSTotal Voting Rights
8th Dec 200610:42 amRNSContract win
30th Nov 20067:01 amRNSBoard Change
23rd Nov 20067:01 amRNSInterim Results
13th Nov 20069:28 amRNSInterim Results Notification
20th Sep 20066:10 pmRNSAGM Statement
29th Jun 20067:02 amRNSFinal Results
13th Jun 20062:43 pmRNSNotice of Results
2nd May 20067:03 amRNSDirectors Shareholding
26th Apr 20061:02 pmRNSDirector/PDMR Shareholding
25th Apr 20062:18 pmRNSResult of EGM
24th Apr 20067:01 amRNSPlacing of Shares
18th Apr 20067:02 amRNSDividend Policy
18th Apr 20067:02 amRNSTrading Statement
3rd Apr 20067:03 amRNSTrading Update
29th Mar 20067:03 amRNSAcquisition
15th Dec 20055:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.